Home /
health Podcasts /
FDA Drug Information Soundcast in Clinical Oncology (D.I.S.C.O.) /
FDA D.I.S.C.O. Burst Edition: FDA approval of Polivy (polatuzumab vedotin-piiq) for previously untreated diffuse large B-cell lymphoma, not otherwise specified, and high-grade B-cell lymphoma

EPISODE · Jun 7, 2023 · 3 MIN

FDA D.I.S.C.O. Burst Edition: FDA approval of Polivy (polatuzumab vedotin-piiq) for previously untreated diffuse large B-cell lymphoma, not otherwise specified, and high-grade B-cell lymphoma

from FDA Drug Information Soundcast in Clinical Oncology (D.I.S.C.O.) · host U.S. Food and Drug Administration, Center for Drug Evaluation and Research

Listen to a soundcast of the April 19, 2023, FDA approval of Polivy (polatuzumab vedotin-piiq) for previously untreated diffuse large B-cell lymphoma, not otherwise specified, and high-grade B-cell lymphoma.

Episode metadata supplied by the publisher feed · Published Jun 7, 2023

Embed this episode

Attribution link and audio player

Ready to play

FDA D.I.S.C.O. Burst Edition: FDA approval of Polivy (polatuzumab vedotin-piiq) for previously untreated diffuse large B-cell lymphoma, not otherwise specified, and high-grade B-cell lymphoma

0:00 3:30

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

輕鬆講講故丨粵語丨暴走的陳老C丨廣東話暴走的陳老C 《輕鬆講講古》

Frequently Asked Questions

How long is this episode of FDA Drug Information Soundcast in Clinical Oncology (D.I.S.C.O.)?

This episode is 3 minutes long.

When was this FDA Drug Information Soundcast in Clinical Oncology (D.I.S.C.O.) episode published?

This episode was published on June 7, 2023.

Can I download this FDA Drug Information Soundcast in Clinical Oncology (D.I.S.C.O.) episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!